Related Experiment Videos

Drug insight: statins and gastrointestinal cancer

Taft P Bhuket1, Peter D R Higgins

  • 1University of Michigan, Ann Arbor, MI, USA.

Nature Clinical Practice. Gastroenterology & Hepatology
|September 30, 2006
PubMed

Insights

Statins, known for lowering lipids, show potential anticancer effects beyond cardiovascular disease prevention. This review examines their role in gastrointestinal cancer treatment and prevention, noting mixed clinical results.

Area of Science:

  • Oncology
  • Pharmacology
  • Gastroenterology

Background:

  • Statins are widely used lipid-lowering drugs with established cardiovascular benefits.
  • Emerging research indicates statins possess biological activities beyond lipid reduction.
  • Preclinical studies suggest statins may have anticancer properties.

Purpose of the Study:

  • To critically review the existing literature on statins in gastrointestinal cancer.
  • To evaluate the role of statins in both the treatment and prevention of GI cancers.
  • To focus on findings from clinical and observational studies.

Main Methods:

  • Systematic review of published clinical and observational studies.
  • Critical evaluation of evidence regarding statin use in gastrointestinal cancers.
  • Analysis of studies focusing on cancer treatment and prevention.

Main Results:

  • Clinical studies on statins for cancer treatment and prevention have yielded conflicting results.
  • Evidence for statins' efficacy in gastrointestinal cancers remains inconclusive.
  • Further research is needed to clarify the role of statins in oncology.

Conclusions:

  • Statins exhibit pleiotropic effects, including potential anticancer activity.
  • The clinical utility of statins for gastrointestinal cancer prevention and treatment requires further investigation.
  • Conflicting data necessitates careful interpretation of current evidence.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...